Brook Preloader

Regina Hodits

Regina is a Partner at Wellington Partners, a leading European venture capital firm committed to backing outstanding entrepreneurs with total funds of €800 million under management.

  • On Board of AYOXXA, Endostim, GTX Medical, Polares Medical, Themis and TRiCares
  • Spokesperson for the Board of the German PE and Venture Capital Association (BVK)
  • Founding investor of Rigontec (acquired by MSD), Sapien (acquired by Medtronic), Middle Peak
  • Medical (acquired by Symetis/Boston Scientific)
  • External director at GlaxoSmithKline’s Respiratory TA Board
  • Led European life science efforts at Atlas Venture
  • Founding investor in Bicycle Therapeutics, F-star and Jenavalve
  • Served in the Board of U3 Pharma (acquired by Daiichi Sankyo), Nitec Pharma (Now part of
  • Horizon Pharma NASDAQ: HYPN), Egalet (NASDAQ: EGLT) and Novamed (acquired by
  • SciClone NASDAQ: SCLN)
  • Worked for Apax Partners and McKinsey & Company
  • Studies Chemical Engineering in Vienna and holds a PhD in biochemistry